Form 4 for KLRS Kalaris Therapeutics, Inc.
Accepted 2022-02-10 00:00:00 ET · period of report 2022-02-10 · accession 0000899243-22-005623 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-10 | 2022-02-10 | KLRS | Bornstein Jeffrey S | Dir | P - Purchase | $8.87 | +5,000 | 35.2K | +17% | +$44.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | P | A | 5,000 | $8.87 | 35,197 | D | — | — |